{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:00:13Z","timestamp":1789729213957,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Abbott Vascular Int"},{"name":"Amgen Cardiovascular"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer Alliance"},{"name":"Daiichi Sankyo Europe GmbH"},{"name":"Alliance Daiichi Sankyo Europe GmbH"},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gedeon Richter Plc"},{"name":"Menarini Int. Op"},{"name":"MSD-Merck & Co"},{"name":"Novartis Pharma AG"},{"DOI":"10.13039\/100017647","name":"ResMed","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017647","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vifor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The European Society of Cardiology (ESC) EURObservational Research Programme (EORP)-Atrial Fibrillation (AF) III Registry aims to identify contemporary patterns in AF management in clinical practice, assess their compliance with the 2016 ESC AF Guidelines, identify major gaps in guideline implementation, characterize the clinical practice settings associated with good vs. poor guideline implementation and assess and compare the 1-year outcome of guideline-adherent vs. guideline non-adherent management strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Consecutive adult AF patients (n\u2009=\u20098306) were enrolled between 1 July 2018 and 15 July 2019, and individual patient data were prospectively collected across 192 centres and 31 participating countries during the 3-month enrolment period per centre. The Registry collected baseline and 1-year follow-up data in the eight main domains: patient demographic\/enrolment setting, AF diagnosis\/characterization, diagnostic assessment, stroke prevention treatments, arrhythmia-directed therapies, integrated AF management, major outcomes (death, non-fatal stroke or systemic embolic event, and non-fatal bleeding event), and the quality of life questionnaire.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The EORP-AF III Registry is an international, prospective registry of care and outcomes of patients treated for AF, which will provide insights into the contemporary patterns in AF management, ESC AF Guidelines implementation in routine practice and barriers to optimal management of this highly prevalent arrhythmia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcaa050","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T11:19:05Z","timestamp":1591096745000},"page":"229-237","source":"Crossref","is-referenced-by-count":22,"title":["Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-6902","authenticated-orcid":false,"given":"Tatjana S","family":"Potpara","sequence":"first","affiliation":[{"name":"School of Medicine, Belgrade University, Dr Subotica 8, 11000 Belgrade, Serbia"},{"name":"Cardiology Clinic, Clinical Centre of Serbia, Visegradska 26, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK"},{"name":"Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0323-4956","authenticated-orcid":false,"given":"Nikolaos","family":"Dagres","sequence":"additional","affiliation":[{"name":"Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J M G","family":"Crijns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands"},{"name":"Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-0197","authenticated-orcid":false,"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, Medical School, University of Birmingham, Edgbaston, Birmingham, UK"},{"name":"University Heart and Vascular Center, UKE Hamburg, Hamburg, Germany"},{"name":"German Center for Cardiovascular Research (DZHK), partner site Hamburg\/Kiel\/L\u00fcbeck, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Arbelo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Institute, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain"},{"name":"Instit d\u2019Investigaci\u00f3 August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Savelieva","sequence":"additional","affiliation":[{"name":"Division of Cardiac and Vascular Sciences, Molecular and Clinical Sciences Research Institute, St George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4680-6734","authenticated-orcid":false,"given":"Radoslaw","family":"Lenarczyk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Congenital Heart Disease and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Silesian Medical University, 9 Curie-Sklodowskiej St., Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1658","authenticated-orcid":false,"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, Centre Hospitalier Universitaire Trousseauet Facult\u00e9 de M\u00e9decine EA7505, Universit\u00e9 de Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P","family":"Maggioni","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme, European Society of Cardiology, 2035 Route des Colles,Biot, 06903 Sophia-Antipolis, France"},{"name":"Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P","family":"Gale","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EORP-AF III Investigators Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"2021050320470853200_qcaa050-B1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2021050320470853200_qcaa050-B2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12913-017-2652-y","article-title":"Cost of illness of atrial fibrillation: a nationwide study of societal impact","volume":"17","author":"Johnsen","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2021050320470853200_qcaa050-B3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"2021050320470853200_qcaa050-B4","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"2021050320470853200_qcaa050-B5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","article-title":"Rate control in atrial fibrillation","volume":"388","author":"Van Gelder","year":"2016","journal-title":"Lancet"},{"key":"2021050320470853200_qcaa050-B6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(16)31277-6","article-title":"Rhythm control in atrial fibrillation","volume":"388","author":"Piccini","year":"2016","journal-title":"Lancet"},{"key":"2021050320470853200_qcaa050-B7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","article-title":"Stroke prevention in atrial fibrillation","volume":"388","author":"Freedman","year":"2016","journal-title":"Lancet"},{"key":"2021050320470853200_qcaa050-B8","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"2021050320470853200_qcaa050-B9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation","volume":"153","author":"Nieuwlaat","year":"2007","journal-title":"Am Heart J"},{"key":"2021050320470853200_qcaa050-B10","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euv269","article-title":"Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"key":"2021050320470853200_qcaa050-B11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.amjmed.2016.09.012","article-title":"Registries in atrial fibrillation: from trials to real-life clinical practice","volume":"130","author":"Mazurek","year":"2017","journal-title":"Am J Med"},{"key":"2021050320470853200_qcaa050-B12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jama.2017.1152","article-title":"Postapproval observational studies of non-vitamin k antagonist oral anticoagulants in atrial fibrillation","volume":"317","author":"Potpara","year":"2017","journal-title":"JAMA"},{"key":"2021050320470853200_qcaa050-B13","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"2021050320470853200_qcaa050-B14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"2021050320470853200_qcaa050-B15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"key":"2021050320470853200_qcaa050-B16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jacc.2010.03.043","article-title":"Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry\u2019s PINNACLE (Practice Innovation And Clinical Excellence) program","volume":"56","author":"Chan","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2021050320470853200_qcaa050-B17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCOUTCOMES.114.001263","article-title":"Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation","volume":"7","author":"Lewis","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2021050320470853200_qcaa050-B18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00325481.2016.1132939","article-title":"Underuse of anticoagulation in patients with atrial fibrillation","volume":"128","author":"Vallakati","year":"2016","journal-title":"Postgrad Med"},{"key":"2021050320470853200_qcaa050-B19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jjcc.2014.07.013","article-title":"Warfarin anticoagulation intensity in Japanese nonvalvular atrial fibrillation patients: a J-RHYTHM Registry analysis","volume":"65","author":"Yamashita","year":"2015","journal-title":"J Cardiol"},{"key":"2021050320470853200_qcaa050-B20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jjcc.2012.12.002","article-title":"Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry","volume":"61","author":"Akao","year":"2013","journal-title":"J Cardiol"},{"key":"2021050320470853200_qcaa050-B21","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"2021050320470853200_qcaa050-B22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1","volume":"65","author":"Friberg","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2021050320470853200_qcaa050-B23","doi-asserted-by":"crossref","first-page":"e0125257","DOI":"10.1371\/journal.pone.0125257","article-title":"Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"2021050320470853200_qcaa050-B24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ahj.2013.12.006","article-title":"Design and rationale of global registry on long-term oral antithrombotic treatment in patients with atrial fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation","volume":"167","author":"Huisman","year":"2014","journal-title":"Am Heart J"},{"key":"2021050320470853200_qcaa050-B25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2011.09.011","article-title":"International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)","volume":"163","author":"Kakkar","year":"2012","journal-title":"Am Heart J"},{"key":"2021050320470853200_qcaa050-B26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/eut263","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events\u2013European Registry in Atrial Fibrillation (PREFER in AF","volume":"16","author":"Kirchhof","year":"2014","journal-title":"Europace"},{"key":"2021050320470853200_qcaa050-B27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ahj.2011.07.001","article-title":"Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF","volume":"162","author":"Piccini","year":"2011","journal-title":"Am Heart J"},{"key":"2021050320470853200_qcaa050-B28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ahj.2014.04.005","article-title":"Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry","volume":"168","author":"Steinberg","year":"2014","journal-title":"Am Heart J"},{"key":"2021050320470853200_qcaa050-B29","doi-asserted-by":"crossref","first-page":"20432","DOI":"10.1038\/srep20432","article-title":"Stroke prevention in atrial fibrillation and \u2018real world\u2019 adherence to guidelines in the Balkan Region: the BALKAN-AF Survey","volume":"6","author":"Potpara","year":"2016","journal-title":"Sci Rep"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcaa050\/33369599\/qcaa050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjqcco\/article-pdf\/7\/3\/229\/37776862\/qcaa050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjqcco\/article-pdf\/7\/3\/229\/37776862\/qcaa050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T20:50:46Z","timestamp":1620075046000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/7\/3\/229\/5854871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6,8]]},"published-print":{"date-parts":[[2021,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcaa050","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2020,6,8]]}}}